Multicenter, multi-site study on the prevalence and determinants of practices that increase the risk of HIV and HCV transmission among people who use drugs (Coquelicot Study). Feasibility phase – January 2001–September 2002. Final report

This report provides a detailed account of the steps involved in setting up and conducting a pilot study of drug users carried out between January 2001 and June 2002 in the city of Marseille. This study first sought to determine the feasibility of a larger-scale cross-sectional data collection (multi-city, multi-site) whose scientific objectives were to describe the characteristics, needs, and risk-taking behaviors of drug users, and to measure the prevalence and incidence of HIV and HCV using biological samples (saliva or blood) within this population. This feasibility phase also provided epidemiological and biological data on a sample of 166 individuals, the analysis of which is included in the report.

Author(s): Emmanuelli J, Jauffret Roustide M, Desenclos JC, Laporte A, Arduin P, Quaglia M

Publishing year: 2003

Pages: 80 p.

In relation to

Our latest news

news

SIBCA 2026: The UrBaCS network presents its solutions for cities and...

news

Physical Activity and Combating a Sedentary Lifestyle: How Does Santé...

news

Etienne Pot Appointed Interim Director General of Santé publique France